Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices

Bibliographic Details
Main Author:	Editorial Article
Format:	Article
Language:	Russian
Published:	Numikom LLC 2015-10-01
Series:	Эпидемиология и вакцинопрофилактика
Online Access:	https://www.epidemvac.ru/jour/article/view/85

Similar Items

Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
by: Starla Hayward, et al.
Published: (2016-04-01)

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.
by: Charles Feldman, et al.
Published: (2020-01-01)

Prevention and Control of Influenza with Vaccines: Recomendations of the Advisory Committee on Immunization Practice
by: Editorial Article
Published: (2015-10-01)

Effect of 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Administrated to Elderly Cancer Patients
by: Wen-YenChiou, et al.
Published: (2018)

Egg Allergy and MMR Vaccine: New Recommendations from the National Advisory Committee on Immunization
Published: (1996-01-01)

Consensus Statement by the Expert Advisory Committee
by: article Editorial
Published: (2012-02-01)

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
by: Anderson, T.C, et al.
Published: (2022)

Social capital and pneumococcal vaccination (PPSV23) in community-dwelling older Japanese: a JAGES multilevel cross-sectional study
by: Yugo Shobugawa, et al.
Published: (2021-06-01)

23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method.
by: Jiwon Lee, et al.
Published: (2021-01-01)

Impact of PCV13 vaccination in Blantyre, Malawi
by: Portia Kamthunzi
Published: (2021-07-01)

Vaccination status (PCV13) of children with pneumococcal meningitis
by: Seidullayeva, Aliya, et al.
Published: (2020-05-01)

Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations
Published: (2012-05-01)

Advisory committee by-laws.
Published: ()

Canada’s National Advisory Committee on Immunization: Celebrating 50 Years
by: Shalini Desai, et al.
Published: (2015-01-01)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting
Published: (2012-12-01)

RESOLUTION OF CONFERENCE OF ADVISORY PANEL ON PNEUMOCOCCAL DISEASE AND VACCINATION IN RUSSIA
by: article Editorial
Published: (2017-02-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2010-12-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2006-02-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2012-12-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2003-02-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2005-02-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2004-02-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2008-04-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2007-07-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2014-12-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2009-03-01)

Front Page and Advisory Committee
by: Salvatore Lorusso
Published: (2002-02-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2014-02-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2012-06-01)

Front page and advisory committee
by: Salvatore Lorusso
Published: (2014-12-01)

Cloning and Expression of the Tibetan Pig Interleukin-23 Gene and Its Promotion of Immunity of Pigs to PCV2 Vaccine
by: Yongle Xiao, et al.
Published: (2020-05-01)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
by: Filippo Ansaldi, et al.
Published: (2020-01-01)

Effectiveness of the 4-H Advisory Committee Process as Perceived by 4-H Professionals and Advisory Committee Members
by: Tassin, Mark Gerard
Published: (2005)

Defining the paediatric nasopharyngeal microbiota during PCV13 vaccine implementation
by: Devine, Vanessa
Published: (2015)

Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience
by: Daleb Abdoulaye Alfa, et al.
Published: (2020-08-01)

Reinforcing Surveillance for Vaccine-Associated Adverse Events: The Advisory Committee on Causality Assessment
by: Robert Pless, et al.
Published: (1996-01-01)

Report of the Advisory Committee on Health Research
Published: (1997-12-01)

Report of official advisory committee meeting.
Published: ()

Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
by: Adamos Hadjipanayis, et al.
Published: (2016-01-01)

A Retrospective study of the Advisory Committee of the CPC Central Committee
by: Zhen-Sheng Pan, et al.
Published: (2011)